 |
|
| Blog results | Results 1 - 10 of about 10,803 for taxol breast cancer. (0.34 seconds) |
| Sorted by relevance Sort by date |
| 8 Feb 2010 by Ming Tan Taxol is one of the most effective chemotherapeutic agents for the treatment of patients with breast cancer. Despite impressive clinical responses initially, the majority of patients eventually develop resistance to Taxol. ... Molecular Cancer - Latest Articles - http://www.molecular-cancer.com/ |
| 14 hours ago Usually the drugs are used Adriamycin and Cytoxan and / or Taxol or Taxotere. This is perhaps not the entire tumor removed, but if not, it can do two things: It is the destruction> Cancer that has spread to various organs, ... breastcancer-walk.com - http://breastcancer-walk.com/ |
| 22 Jan 2010 by admin In this study, we combine taxol chemotherapy and miR-21 inhibitor treatment via polyamidoamine (PAMAM) dendrimers vector to evaluate the effects of combination therapy on suppression of breast cancer cells. ... Immortality Medicine - http://www.immortalitymedicine.tv/ |
| 2 Jan 2010 by phanz Herceptin has demonstrated unprecedented efficacy in treating both early and advanced (metastatic) HER2 positive breast cancer. Given on its own as monotherapy as well as in combination with or following standard chemotherapy, ... Pat's Breast Cancer Journey - http://phanz.wordpress.com/ [ More results from Pat's Breast Cancer Journey ] |
| 6 Feb 2010 The most common medicine is tamoxifen, which blocks the estrogen in the breast, thus helping slow the growth and dividing of cancer cells. Other medications include Herceptin, Ellence, Taxol, Docetaxel and Aromasin and they are used to ... Mona Styr - http://www.monastyr.info/ |
| 1 Feb 2010 Though sales of the Taxol peaked at $1.6 billion a decade ago and have declined since going off patent, it and its generic version remain one of the world's most successful cancer drugs. And, according to the authors of the ... A mitotic inhibitor, paclitaxel is used primarily for the treatment of lung, ovarian, breast, and head and neck cancers. It also is used to treat advanced forms of Kaposi's sarcoma and to prevent restenosis. In their study, when the researchers ... Überfeed of All GenomeWeb Content - http://feeds.genomeweb.com/genomeweb |
| 19 Dec 2009 by Ketan Mukherjee About 20-25% of breast cancers lead to over-expressing of HER2, and this leads to an aggressive and increased growth of cancerous cells and a breast cancer prognosis which is much worse than before. As of now, Herceptin is the only FDA ... TopNews New Zealand - http://topnews.net.nz/ |
| 8 Jan 2010 Jan 6, 2010 - NeoPharm, Inc. (Other OTC NEOL.PK) today announced the results of a Phase II clinical trial of Liposome-Entrapped Paclitaxel (LEP) an active compo. Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
| 8 Feb 2010 Phase 3 study of eribulin for locally advanced or metastatic breast cancer. October 30, 2009. Eisai announced preliminary results from a recently completed Phase 3 study with eribulin mesylate (E7389) in patients with locally advanced ... Latest articles from MPR - http://www.empr.com/ [ More results from Latest articles from MPR ] |
| 31 Dec 2009 by albuminmidwest All patients in the conditional, sponsored by American Bioscience, Inc., had progressive metastatic breast cancer while being treated with Taxol or Taxotere in the metastatic setting, or had a relapse within 12 months of adjuvant taxane ... Albumin midwest - http://albuminmidwest.rangdebasanti.com/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
